Replimune Group Inc
NASDAQ:REPL

Watchlist Manager
Replimune Group Inc Logo
Replimune Group Inc
NASDAQ:REPL
Watchlist
Price: 9.95 USD -2.26% Market Closed
Market Cap: 780.5m USD

Wall Street
Price Targets

REPL Price Targets Summary
Replimune Group Inc

Wall Street analysts forecast REPL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for REPL is 12.82 USD with a low forecast of 10.1 USD and a high forecast of 18.9 USD.

Lowest
Price Target
10.1 USD
2% Upside
Average
Price Target
12.82 USD
29% Upside
Highest
Price Target
18.9 USD
90% Upside
Replimune Group Inc Competitors:
Price Targets
SOBI
Swedish Orphan Biovitrum AB (publ)
13% Upside
XGN
Exagen Inc
124% Upside
300142
Walvax Biotechnology Co Ltd
36% Downside
KURA
Kura Oncology Inc
219% Upside
300685
Amoy Diagnostics Co Ltd
41% Upside
AMGN
Amgen Inc
2% Upside
GLPG
Galapagos NV
12% Upside
688177
Bio-Thera Solutions Ltd
61% Upside

Revenue
Forecast

Revenue Estimate
Replimune Group Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Replimune Group Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
Replimune Group Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-35%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is REPL's stock price target?
Price Target
12.82 USD

According to Wall Street analysts, the average 1-year price target for REPL is 12.82 USD with a low forecast of 10.1 USD and a high forecast of 18.9 USD.

Back to Top